A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes
Titel:
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes
Auteur:
Home, Philip Shankar, R. Ravi Gantz, Ira Iredale, Carol O'Neill, Edward A. Jain, Lokesh Pong, Annpey Suryawanshi, Shailaja Engel, Samuel S. Kaufman, Keith D. Lai, Eseng